These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12890311)

  • 21. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
    McQuillin A; Rizig M; Gurling HM
    Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice.
    Böer U; Cierny I; Krause D; Heinrich A; Lin H; Mayr G; Hiemke C; Knepel W
    Neuropsychopharmacology; 2008 Sep; 33(10):2407-15. PubMed ID: 18046304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The calcium second messenger system in bipolar disorders: data supporting new research directions.
    Dubovsky SL; Murphy J; Christiano J; Lee C
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):3-14. PubMed ID: 1320969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.
    Manji HK; Lenox RH
    Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder.
    Fatemi SH; Reutiman TJ; Folsom TD
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1090-5. PubMed ID: 19754458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the Na(+)-K(+)-ATPase the link between phosphoinositide metabolism and bipolar disorder?
    el-Mallakh RS; Li R
    J Neuropsychiatry Clin Neurosci; 1993; 5(4):361-8. PubMed ID: 8286932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signal transduction pathways in the pathophysiology of bipolar disorder.
    Gawryluk JW; Young LT
    Curr Top Behav Neurosci; 2011; 5():139-65. PubMed ID: 25236554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.
    Herteleer L; Zwarts L; Hens K; Forero D; Del-Favero J; Callaerts P
    Psychopharmacology (Berl); 2016 May; 233(9):1751-62. PubMed ID: 26852229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
    Sokolski KN; Denson TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How can the mood stabilizer VPA limit both mania and depression?
    Cheng L; Lumb M; Polgár L; Mudge AW
    Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transduction pathways. Molecular targets for lithium's actions.
    Manji HK; Potter WZ; Lenox RH
    Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.